This is a medical procedure called a Peritoneovenous Shunt. It's a type of shunt used to drain fluid from the abdomen. The fluid is collected in the abdomen and then continuously pumped into a vein in the neck. This helps reduce swelling (ascites) in the abdomen. It's used when other treatments haven't worked.
Every report comes from a Lived member, sent anonymously.
Have you had Peritoneovenous Shunt for Ascites?
A peritoneovenous shunt is a thin tube placed under the skin that drains ascites, fluid that has built up in the abdomen, into a large vein near the heart. One end lies inside the abdominal cavity and the other is threaded into a vein in the neck or upper chest. A one-way valve lets fluid move toward the vein but stops blood from flowing back. The original LeVeen design relies on pressure alone. The Denver design adds a small pump chamber under the skin over the lower ribs that the person can press to keep fluid moving. The shunt is used for refractory ascites: fluid that keeps returning despite a low-salt diet and diuretics (water pills), so that it has to be drained repeatedly with a needle, a procedure called paracentesis. Most people who receive one have advanced cirrhosis of the liver or cancer that has spread to the lining of the abdomen. Less often it treats chylous ascites, a milky, fat-rich fluid that can leak after surgery near lymph vessels. In that setting the shunt is often removed once the leak has healed. For cirrhosis, a peritoneovenous shunt is rarely the first choice. A liver transplant is the only treatment that addresses the underlying liver failure, and a TIPS (transjugular intrahepatic portosystemic shunt, a channel placed inside the liver to lower pressure in its blood supply) is usually preferred for people who need frequent drainage and are suitable for it. Because of its complication rates, major liver societies give the peritoneovenous shunt only a limited role. It is mainly a palliative option, meant to ease swelling and spare repeated drainage when those other approaches are not possible. For cancer-related ascites the evidence is weak and specialists disagree; one cancer guideline advises against it for widespread abdominal cancer because complications are frequent and can be fatal.
Because the shunt sends abdominal fluid straight into the bloodstream, the team first checks that both the fluid and the body can handle it. A sample of the fluid is tested for infection, since infected ascites (bacterial peritonitis) rules the procedure out. Blood tests look at kidney function, clotting and bilirubin, a liver blood test. Blood-stained fluid and a high bilirubin level are linked to a higher risk of a serious clotting complication, and poor kidney function makes the shunt less likely to help. The heart is assessed, often with an echocardiogram (an ultrasound of the heart), because the returning fluid adds volume the heart must handle. Some centers also look for varices, enlarged veins in the esophagus that can bleed, with an endoscopy and treat large ones beforehand. Tell the team about blood thinners, diuretics and any heart or kidney problems, and follow their instructions about which medicines to adjust and when to stop eating and drinking before sedation. Antibiotics are commonly given around the time of the procedure to lower the chance of infection.
The shunt can be placed by an interventional radiologist through small punctures guided by ultrasound and X-ray, or by a surgeon through a small incision in the upper abdomen. Depending on the center and the person's health, it is done with a local anesthetic plus sedation given through an IV (a small tube in a vein), or under general anesthesia. The abdominal end of the tube is placed in the fluid-filled space, the tubing is tunneled under the skin of the chest wall, and the other end is guided into a large vein so its tip sits near the heart. With a Denver shunt, the pump chamber is set in a pocket under the skin over the lower ribs. Many teams drain a large volume of fluid during the procedure, and some replace part of it with IV fluid, so that a sudden rush of ascites into the bloodstream does not overload the heart or set off clotting problems.
People stay in the hospital afterward so the team can watch for the main early problems. Blood tests and a chest X-ray are repeated over the first days to look for strain on the heart and for abnormal clotting. Mild changes in these results are common in the first couple of days and usually settle within about a week. Soreness at the incisions and over the pump pocket is expected. When the shunt works, abdominal swelling usually eases within days. In cirrhosis the fluid typically falls to a steady, lower level rather than disappearing completely, so a low-salt diet and other treatment may still be needed. In cancer-related ascites, relief often starts within a couple of days but may last only weeks to months, partly because of the underlying illness. With a Denver shunt, the team teaches you how to press the pump chamber, usually a set number of presses once or twice a day while lying down, and what a normal press and refill feel like. Regular pumping helps keep the tubing from clogging. Follow-up visits check abdominal size, blood tests and how the shunt is working. Contact the care team right away if the abdomen swells again, you become newly or increasingly short of breath, you develop a fever, fluid leaks from an incision, or the pump becomes hard to press or slow to refill. A blocked shunt can often be cleared by flushing it through the pump chamber; sometimes it has to be revised or replaced.
A peritoneovenous shunt carries more serious risks than repeated drainage, which is the main reason it is reserved for carefully selected people. The most important complications come from ascitic fluid entering the circulation directly. The extra volume can bring on heart failure, reported in roughly 3 to 16 percent of people. Substances in the fluid can also trigger disseminated intravascular coagulation (DIC), widespread abnormal clotting that uses up the blood's clotting factors and can lead to bleeding. Reported DIC rates vary from almost none to about a third, depending on patient selection and technique, and are higher with blood-stained fluid or high bilirubin. Infection, including bloodstream infection (sepsis), has been reported in up to about 15 percent, and blood clots can form in the shunt or elsewhere. These complications can be life-threatening, and the risk of serious problems or death in the weeks after placement is highest in people with very advanced liver failure or poor kidney function. In one large series of people with cirrhosis, about 1 in 10 died within two months of placement, with the highest rates among those with the most severe liver failure. Blockage is the most common long-term problem, affecting roughly 16 to 45 percent of shunts, usually from clot or fibrin (a stringy clotting protein) inside the tubing. When it happens, the swelling returns and another procedure may be needed. In one large series, about half of blockages happened within the first six months. With cancer-related ascites there are added concerns about lung injury and about carrying cancer cells into the bloodstream. The shunt is not used when the fluid is infected or very thick, or when it is trapped in separate pockets that the tube cannot drain. Outcomes depend heavily on the underlying illness. People who receive these shunts usually have advanced disease, and their survival is shaped mainly by that disease. More advanced liver failure and poor kidney function are linked to less benefit and a worse outlook.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Peritoneovenous Shunt, what to expect, or ask the community a question.